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Regulation of deubiquitinating enzyme (DUB) activity is an essential step for proper function of cellular
ubiquitin signals. UAF1 is a WD40 repeat protein, which binds and activates three important DUBs, USP1,
USP12 and USP46. Here, we report the crystal structure of the USP12-Ub/UAF1 complex at a resolution of
2.8 Å and of UAF1 at 2.3 Å. In the complex we find two potential sites for UAF1 binding, analogous to what
was seen in a USP46/UAF1 complex. In line with these observed dual binding states, we show here that
USP12/UAF1 complex has 1:2 stoichiometry in solution, with a two-step binding at 4 nM and 325 nM
respectively. Mutagenesis studies show that the fingers sub-domain of USP12 interacts with UAF1 to
form the high affinity interface. Our activation studies confirm that the high affinity binding is important
for activation while the second UAF1 binding does not affect activation. Nevertheless, we show that this
two step binding is conserved in the well-studied USP12 paralog, USP1. Our results highlight the inter-
faces essential for regulation of USP12 activity and show a conserved second binding of UAF1 which could
be important for regulatory functions independent of USP12 activity.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction 2007). An interesting form of regulation is seen in a small sub-Ubiquitination of proteins is a reversible post-translational
modification that is critical for almost any cellular process. The
control of these crucial pathways lies in the precise regulation of
ubiquitinating and deubiquitinating enzymes (DUBs). DUBs are
carefully regulated intra-cellular peptidases that cleave ubiquitin
from target substrates. There are approximately 90 DUBs in the
human genome, in 5 different families (Clague et al., 2013;
Komander et al., 2009). The most abundant are the ubiquitin speci-
fic proteases (USPs) with 60 members that share a conserved USP
catalytic domain, in which the ubiquitin core is held by the ‘‘fin-
gers” while the catalytic centre lies between the ‘‘palm” and
‘‘thumb” subdomains. Despite this common catalytic core, the
USP family members have many different modes of regulation
(Sahtoe and Sixma, 2015).
Such regulation can take place in different ways and at different
sites. USPs are regulated by changes in the catalytic domain, where
the catalytic triad may be misarranged (Hu et al., 2002), via addi-
tional domains within the protein itself (Clerici et al., 2014;
Faesen et al., 2011a), via post translational modifications
(Nicassio et al., 2007), or by sub-cellular localization (Row et al.,family of USPs, that includes USP1, USP12 and USP46. These three
proteins are activated by complex formation with a WD40 repeat
protein called UAF1 (USP1 associated factor, also known as
WDR48) that leads to increased catalytic turnover for these
enzymes (Cohn et al., 2007).
USP12 and USP46 are small proteins (370 and 366 residues
respectively) with a highly conserved catalytic domain and high
sequence similarity (88% identity). The related paralog USP1 (31%
identity) is much larger (785 residues), due to additional inserts
within its catalytic domain. The USP12/UAF1 and USP46/UAF1
complex can be further activated by binding to a secondWD repeat
protein, WDR20. This hyper-activation is not observed for the
USP1/UAF1 complex (Kee et al., 2010). The lack of hyper-
activation in USP1 could be due to the presence of the long inserts
which might prevent it from interacting with WDR20. All three
enzymes have low intrinsic activity in isolation and binding to
UAF1 leads to activation which was shown to be due to an increase
in kcat with no drastic change in the KM (Cohn et al., 2007; Faesen
et al., 2011b; Villamil et al., 2012a). The exclusive kcat activation is
unusual for DUBs as most intermolecular activators (except GMPS)
affect substrate binding (Faesen et al., 2011b).
The UAF1 regulation of this subfamily of DUBs has attracted
considerable attention due to the biological importance of the
enzymes involved. USP1 is important in DNA repair, where it acts
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and DNA-damage avoidance pathways (Huang et al., 2006; Nijman
et al., 2005). It is also found to deubiquitinate the ID family of tran-
scriptional regulators (Williams et al., 2011). Due to these impor-
tant functions, USP1 is considered a major possible drug target
(Liang et al., 2014). USP46 plays important roles in neurobiology,
as a small deletion mutation in USP46 leads to neurological effects
in mice, including anxiety and changes in learning and memory
(Imai et al., 2013; Zhang et al., 2011). The molecular basis for these
effects is not yet clear. For USP12 several possible roles have been
described. It is involved in stabilizing the Akt phosphatases result-
ing in decreased levels of pAkt (Gangula and Maddika, 2013). It has
also been reported that USP12 and USP46 deubiquitinate histone
H2A and H2B thereby playing a role in Xenopus development
(Joo et al., 2011). Recently USP12 was shown to stabilize the T-
cell receptor complex at the cell surface by deubiquitinating TCR
adaptor proteins LAT and Trat1 (Jahan et al., 2016).
Several studies have tried to uncover the detailed mechanism of
USP1/12/46 activation by UAF1 and also the interfaces involved in
the formation of this complex. It was suggested that UAF1 binding
modulates the active site conformation of USP1 resulting in a pro-
ductive catalytic triad and also that phosphorylation of Ser313 is
necessary for its interaction (Villamil et al., 2012a,b). Other studies
have shown that the regions in and around the fingers domain of
USP1 might be necessary for UAF1 binding (Olazabal-Herrero
et al., 2015). Recently the crystal structure of the USP46-Ub and
its complex with UAF1 were determined. In these structures two
possible interfaces for UAF1 binding and activation were identified.
The authors used mutational analysis to show that Interface 1 is
critical for UAF1 binding and activation (Yin et al., 2015).
Here we present the structure of USP12-Ub/UAF1580 complex
which was solved at a resolution of 2.8 Å and compare it to the
UAF1 structure alone. Intriguingly, we find that these structures
resemble the USP46/UAF1 complex structure (Yin et al., 2015),
including the presence of the second binding site. We then show
that in solution USP12 can bind to a second molecule UAF1, but
with lower affinity. We confirm for USP12 that Interface 1 at the
fingers site is the high affinity interface while the second low affin-
ity interface could be at the backside of the ubiquitin binding cleft.
Moreover, mutagenesis studies suggest that the first binding event
at the fingers is responsible for activation while the second binding
does not influence activity.2. Materials and methods
2.1. Plasmids and cloning
Human USP12, USP46, USP1 and UAF1 constructs were
obtained from Martin Cohn. The USPs were cloned into pFastbac-
HTb vector and UAF1 was cloned into pFastbac1 (N-terminal Strep
tag) for insect cell expression. The sequence verified insert contain-
ing pFastbac vectors were transformed into DH10Bac cells for bac-
mid preparation. The recombinant bacmid was used for
transfection of Spodoptera frugiperda (sf9) insect cells to produce
the recombinant baculovirus. USP12WT (24–370) and USP46 (8–
366) were also cloned into the pGEX and pET bacterial expression
vectors of the NKI LIC suite, respectively (Luna-Vargas et al., 2011).
All USP12 mutants were made using the QuikChange site directed
mutagenesis method on pGEX USP12 bacterial construct.2.2. Protein expression and purification
N-terminal His-tagged USP1 (21–785) and USP12FL were
expressed using Baculovirus expression in sf9 insect cells. After
72 h of infection the cells were harvested in 20 mM Tris (pH 8.0)+ 200 mM NaCl + 2 mM TCEP + protease inhibitor (lysis buffer)
and lysed by sonication. The lysed cells were spun down
(21,000 rpm for 1 h) and the lysate was loaded on a His-affinity
column (GE, USA). The column was washed with lysis buffer sup-
plemented with 50 mM Imidazole (pH 8.0) followed by elution
with lysis buffer supplemented with 500 mM imidazole. The His-
USP1 elution fractions were concentrated and loaded on a size
exclusion chromatography column (Superdex 200, GE, USA) equili-
brated in GF buffer (20 mM HEPES (pH 7.5) + 150 mM NaCl + 2 mM
DTT) following which the protein fractions were concentrated up
to 4.5 mg/ml and stored in 80 C. The USP12FL and USP46FL frac-
tions were incubated with TEV protease and dialyzed overnight in
lysis buffer without imidazole. The dialysed protein sample was
then loaded on a His-affinity column where the protein was
obtained in the wash fractions. The protein containing fractions
were then concentrated and loaded on a size exclusion chromatog-
raphy column (Superdex 200, GE, USA) equilibrated in GF buffer
following which protein fractions were concentrated up to 6 mg/
ml and stored in 80 C.
N-terminal GST-tagged USP12WT and mutants were expressed
in E. coli. The cells were induced with 0.2 mM IPTG at 18 C for
10–12 h followed by which they were harvested in lysis buffer
and lysed by sonication. The lysate was loaded on a GST-affinity
column and washed with lysis buffer followed by elution with lysis
buffer supplemented with 20 mM Glutathione. The protein con-
taining fractions were then concentrated and loaded on a size
exclusion chromatography column (Superdex 200, GE, USA) equili-
brated in GF buffer following which protein fractions were concen-
trated up to 15 mg/ml and stored in 80 C.
N-terminal His-tagged USP46 (8–366) was expressed in E. coli.
The cells were induced with 0.5 mM IPTG at 20 C for 16 h fol-
lowed by which they were harvested in 20 mM Tris (pH 7.5),
150 mM NaCl, 10 mM Imidazole (pH 8.0) and 5 mM beta-
mercaptoethanol (lysis buffer) and lysed by sonication. The lysate
was loaded on a Ni-affinity column and washed with lysis buffer
supplemented with 50 mM imidazole followed by elution with
lysis buffer supplemented with 500 mM imidazole. USP46 was
incubated with TEV protease and dialysed overnight in lysis buffer
without imidazole. The dialysed protein sample was then loaded
on a His-affinity column where the protein was obtained in the
wash fractions. USP46 was loaded on a size exclusion chromatog-
raphy column (Superdex 200, GE, USA) equilibrated with 20 mM
Tris (pH 7.5), 150 mM NaCl and 2 mM DTT.
UAF1FL and UAF1580 were also purified from sf9 insect cells and
were lysed in similar conditions as the USP purifications. The UAF1
lysates were loaded on a Strep-affinity column (IBA life sciences)
and washed with 50 mM Tris (pH 8.0) + 150 mM NaCl + 2 mM
TCEP (wash buffer). The strep-UAF1 protein was then eluted using
wash buffer supplemented with 2.5 mM Desthiobiotin. The protein
containing fractions were concentrated and loaded on a size exclu-
sion chromatography column (Superdex 200, GE, USA) equilibrated
in GF buffer. The fractions corresponding to the peak were col-
lected. UAF1 samples were treated with 10 mM iodoacetamide to
prevent background DUB activity due to minute amounts of co-
purified insect cell DUBs. Following iodoacetamide treatment the
protein fractions were re-purified using size exclusion chromatog-
raphy (Superdex 200, GE, USA). The protein fractions were then
concentrated up to 10 mg/ml and stored in 80 C.
The USP/UAF1 complexes were co-expressed in baculovirus
infected sf9 insect cells. USP/UAF1 complexes were purified by first
carrying out a His-affinity purification followed by Strep-tag (IBA
life Sciences) affinity purification as described above. The protein
fractions were then concentrated and loaded on a size exclusion
chromatography (Superdex S200, GE, USA) equilibrated in GF buf-
fer. The protein containing fractions were concentrated up to 5 mg/
ml and stored at -80 C.
S. Dharadhar et al. / Journal of Structural Biology 196 (2016) 437–447 439Covalent complexes of USP46 and USP12FL/UAF1580 with Ub-
VME and Ub-PRG respectively were generated under reducing con-
ditions at 4 C for 12–16 h. The USP46 reaction was very slow and
only 50% of the enzyme reacted to Ub-VMEwhereas approximately
80% of the USP12FL/UAF1580 complex reacted to the Ub-PRG probe.
The reacted USPs were then purified from the excess probe by
using a size exclusion chromatography column (Superdex 200,
GE, USA) equilibrated in GF buffer. The purified USP-Ub complex
was then concentrated and stored at -80 C.2.3. Crystallization and structure determination
USP12 and UAF1 crystals were obtained by sitting drop vapour
diffusion experiment at 20 C using equal ratio of protein and
mother liquor solution. UAF1580 was setup for crystallization at
8 mg/ml and crystals were obtained in 20% PEG3350, 200 mM
Tri-Sodium Citrate, Bis-Tris Propane pH 6.5. USP12FL-Ub-PRG/
UAF1580 was setup at 5 mg/ml and crystals were obtained in 3.2%
PEG4000, 0.1 mMMMT pH 6.5 and 0.1 mM TCEP. The crystals were
cryo-protected by brief washing in mother liquor solution with
30% glycerol prior to flash freezing in liquid nitrogen. Diffraction
data were collected at the Swiss Light Source beamline PXIII at
100 K.
USP46-Ub-VME at 8 mg/ml was set up for crystallization by sit-
ting drop vapour diffusion experiment at 20 C. Crystals were
obtained in 0.96 M Sodium Citrate pH 7.5 and 0.1 mM ZnCl2 with
protein: precipitant ratio 1.5: 1. The crystals were cryo-protected
by brief washing in mother liquor solution with 20% glycerol prior
to flash freezing in liquid nitrogen. Diffraction data were collected
at the European Synchrotron Radiation Facility (ESRF) beamline
ID14-1 at 100 K.
Crystallographic data were processed with XDS (Kabsch, 2010)
or iMOSFLM (Battye et al., 2011) and scaled using XSCALE
(Kabsch, 2010) or Aimless from the CCP4 suite (Winn et al.,
2011). The USP46-Ub-VME structure was solved by molecular
replacement using the USP2-Ub model (PDB 2IBI) in Phaser
(McCoy et al., 2007) followed by automated model building using
ARP/WARP (Langer et al., 2008). The UAF1 (9–580) structure was
solved by molecular replacement (PDB-1VYH) in Phaser (McCoy
et al., 2007) followed by automated model building using ARP/
Warp (Langer et al., 2008). The USP12FL-Ub/UAF1580 structure
was solved by molecular replacement using the USP46, UAF1580
and ubiquitin structures as search models in Phaser. All structures
were refined by Phenix (Adams et al., 2010), autoBUSTER (Smart
et al., 2012), Refmac (Murshudov et al., 1997), PDB_REDO
(Joosten et al., 2014) and models were built using COOT (Emsley
et al., 2010). Interface analysis was performed with PISA
(Krissinel and Henrick, 2007). All structure figures were generated
using PyMOL (Schrödinger, LLC).2.4. Size exclusion chromatography Multi Angle Laser Light Scattering
(SEC-MALLS)
The SEC-MALLS experiments were performed using the mini-
Dawn Tristar light scattering detector (Wyatt technologies, USA)
in line with size exclusion chromatography. After equilibration of
the Superdex 200 10/300 GL and the Superose 6 increase 10/300
GL (GE, USA) in buffer containing 20 mM HEPES (pH 7.5),
150 mM NaCl, 2 mM DTT, the USP12FL-Ub/UAF1580 (8 lM) and
the USP1/UAF1FL complex (6 lM) were loaded on the Superdex
200 10/300 GL while the USP12FL-Ub/UAF1FL sample (42 lM) was
loaded on the Superose 6 increase 10/300 GL (GE, USA). Molecular
weight estimation was done by using the refractive index signal as
measure of the concentration with the Astra software (Wyatt Tech-
nologies, USA).2.5. Size exclusion chromatography – small angle X-ray scattering
(SEC-SAXS)
USP12FL-Ub/UAF1FL purified from insect cells was concentrated
up to 38 lM. The buffer used for the size exclusion chromatogra-
phy was also used for SEC-SAXS experiment on the BM29 SAXS
beamline at the ESRF. Following equilibration, 30 ll of the purified
USP12FL-Ub/UAF1FL was loaded on the Superdex 200 5/150 GL (GE,
USA) and 1500 successive 1 s frames were collected through the
protein elution peak. The data were normalized to the intensity
of the transmitted beam and radially averaged; the scattering of
the solvent-blank (derived from the buffer run) was subtracted.
Data were analysed using the ATSAS software package (Svergun
et al., 2001). A moving set of 10 or 20 frames was analysed across
the high-intensity peak to estimate molecular weight from various
methods (DATPOROD (Konarev et al., 2006), excluded volume from
DAMMIF model (Franke and Svergun, 2009) and SAXS MoW2
(Fischer et al., 2010)) and fit the data to the crystallographic struc-
tures in CRYSOL (Svergun et al., 1995). Frames prior to 670 and
frames latter than 910 were considered too noisy or weak for anal-
ysis. OLIGOMER (Konarev et al., 2003) was used to perform a fit to
the experimental curve from different possible models of the com-
plex and determine volume fractions of each component. Several
OLIGOMER runs were performed using the 2:1 complex, both 1:1
complexes and UAF1 alone as models in different combinations.
2.6. Ub-rhodamine enzymatic assays
Enzymatic activity was followed as release of fluorescent rho-
damine from the quenched Ub-Rho substrate, providing a direct
readout for DUB activity. The fluorescent intensity was measured
using Pherastar plate reader (BMG LABTECH GmbH, Germany).
Activity of USP12WT at varying concentrations of UAF1FL (20–
1250 nM) was tested at 100 nM of USP12WT and at a single sub-
strate concentration of 1 lM. Activity was quantified by calculating
the initial rates and plotted as a function of UAF1FL concentration.
100 nM of enzyme was used against different concentrations of the
minimal substrate (32–0.25 lM) for the Michaelis Menten analy-
sis. The initial rates were then plotted against substrate concentra-
tion and fitted with a Michaelis Menten model using non-linear
regression in GraphPad Prism 6 software (GraphPad Software Inc,
USA).
2.7. Binding assays
Surface Plasmon Resonance experiments were carried out to
test binding of His-USP1 and Gst-USP12WT to UAF1FL in the Biacore
T200 system (GE, USA). The SPR buffer for Gst-USP12WT and
mutants consisted of 20 mM HEPES 7.5, 150 mM NaCl, 20% glyc-
erol, 0.05% Tween-20, 2 mM TCEP (Tris (2-carboxyethyl) phosphine
hydrochloride) and 1 mg/ml dextran. The SPR buffer for His-USP1
had 300 mM NaCl to neutralize any unspecific interaction with
Ni on the chip surface and the rest of the components were iden-
tical. The Gst-USP12 was immobilized via goat anti-GST antibody
that was pre immobilized to the CM5 chip using amine coupling.
The His-USP1 was directly immobilized to the surface of NTA chip
via His-tag. The binding experiments were carried out in the single
cycle kinetics mode with 5 sequential injection of UAF1FL in each
cycle. An initial experiment with 5 injections from 1 nM to
10 lM and a more detailed assay with 15 injections from
0.56 nM to 2.56 lM were carried out. Data from a reference flow
cell, run in parallel with an empty chip (in case of NTA immobiliza-
tion) or with GST (in case of anti-GST immobilization) were sub-
tracted from the signal using the Biacore T200 Evaluation
Software. Final analysis and the figures were done using GraphPad
Prism 6 (GraphPad Software Inc, USA).
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3.1. Crystal structures of USP46, UAF1580 and USP12FL-Ub/UAF1580
complex
To study how the regulator UAF1 modulates the activity of
USPs, we purified the human USP46, human USP12 and several
constructs of the human UAF1. We refer to UAF1 (9–580) as
UAF1580 and to UAF1 (9–677) as UAF1FL (Fig. 1a). By reaction
of USP46 and USP12 with suicide inhibitors of ubiquitin, Ub-
VME and Ub-PRG respectively, we could create covalentlyA
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Fig. 1. Crystal structure analysis shows two possible binding options for USP12. A) Cons
representation. C) Crystal structure of UAF1580 coloured in a rainbow representation. D)
Zoomed Interface 1 between UAF1580 and USP12FL-Ub showing the interface residues. F)
Zoomed Interface 2 between UAF1580 and USP12FL-Ub showing the interface residues. (linked USP-Ub complexes, which were used for crystallization
attempts.
We generated well diffracting crystals for USP46-Ub (1.85 Å),
USP12FL-Ub/UAF1580 (2.8 Å) and UAF1580 (2.3 Å). All three crystal
structures were solved by molecular replacement where the cova-
lent USP2-Ub complex model (2IBI) was used for the USP46-Ub
structure and the protein PAF-AH (1VYH) was used as a model
for UAF1580. The resulting structures of USP46-Ub and UAF1580
were used as models for the USP12FL-Ub/UAF1580 complex. All
three structures were refined to acceptable R-factors and good
geometry (Table.1).H214 R217
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tructs used for the present study. B) Crystal structure of USP46-Ub-VME in cartoon
Crystal structure of USP12FL-Ub/UAF1580 showing UAF1580 bound to Interface 1. E)
Crystal structure of USP12FL-Ub/ UAF1580 showing UAF1580 bound to Interface 2. G)
Colours in panel B, D–G: Ub in yellow, other proteins as in A).
Table 1
Crystallography details.
Data collection
USP46-UbVME UAF1580 USP12-UbPRG/
UAF1580
Wavelength (Å) 0.93 0.92 1.00
Resolution (Å) 28.41–1.85
(1.90–1.85)
48.97–2.30
(2.35–2.30)
47.41–2.79
(2.92–2.79)
Space Group C 2 2 21 P 2 21 21 I 2 2 2
Unit Cell a, b, c (Å) 91.95 104.66
135.31
73.30 131.60
148.67
103.68 152.82
182.93
CC1/2 0.999 (0.720)⁄ 0.999 (0.585) 0.995 (0.638)
Rmerge 0.12 (0.84) 0.05 (1.0) 0.08 (0.72)
Rpim 0.04 (0.84) 0.06 (0.57)
I/rI 17.68 (2.0) 16.1 (1.4) 10.4 (1.6)
Completeness (%) 98.8 (99.7) 99.6 (95.9) 99.3 (94.8)
Redundancy 3.56 (3.3) 4.5 (4.1) 4.5 (4.3)
Refinement
Unique Reflections (nr) 55,291 64,580 36,148
Atoms total (nr) 3442 8586 7290
Protein atoms (nr) 3192 8195 7266
Solvent atoms (nr) 250 391 24
B-factors 31.9 58.3 72.4
TLS groups 4 4 4
Rwork/Rfree (%) 16.6/19.4 18.5/22.4 20.8/25.9
Rmsd bond lengths (Å) 0.017 0.007 0.014
Rmsd bond angles () 1.758 1.235 1.642
Ramachandran (%)
Preferred/outliers
97.89/0 97.27/0.30 95.5/0.34
Molprobity score 1.01 0.82 1.77
PDB code 5L8H 5L8E 5L8W
High resolution shell in parentheses; (⁄ – Reprocessed with aimless).
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domain with a catalytic centre in the catalytically proficient state
(Fig. 1b). The crystallization contained only 50% of the Ub-bound
form, but the crystal was fully modified, indicating a preferential
crystallization of the ubiquitin-bound form. This structure is in
good agreement with the recently published structure of USP46
((5CVM), RMSd on 308 Ca: 0.3 Å). The structure of UAF1580 forms
a 7 bladed b-propeller with an ancillary domain (Fig. 1c), although
WD40 domain predictions obtained from the protein sequence
predicted 8 blades. The first N-terminal residues (13–24) are pre-
sent in the ancillary domain and the following residues from 25
to 360 form the 7 bladed b-propeller. The predicted eighth blade
(361–400) forms the expected 4-stranded sheet but is located in
the ancillary domain where it sits on top of a b sheet in which
the N-terminal residues form an integral part. The UAF1580 struc-
ture is very similar to the recently published structure of UAF1
((5CVL), RMSd on 517 Ca: 1.2 Å).
In the crystal lattice of the USP12FL-Ub/UAF1580 complex, the
asymmetric unit contains one molecule of USP12 and one molecule
of UAF1. However, USP12 makes two possible interfaces with UAF1
in these crystals, one on the fingers sub-domain (Interface 1)
(Fig. 1d, e) and the other on the backside of the ubiquitin binding
cleft (Interface 2) (Fig. 1f, g). The interactions in Interface 1 are
dominated by hydrophilic and charged interactions, with 794 Å2
and 698 Å2 buried surface area on USP12 and UAF1580 respectively
(Fig. 1e). The Interface 2 is mostly hydrophobic and buries a surface
area of 1030 Å2 and 1111 Å2 on USP12 and UAF1580 respectively
(Fig. 1g). Intriguingly the same crystal packing was seen for the
USP46/UAF1 complex (PDB code: 5CVN) that was published during
the refinement of our structures (Yin et al., 2015). In that publica-
tion the authors confirmed by mutational analysis that Interface 1
is the relevant interface for activation. USP46/UAF1 was crystal-
lized in the same space group, with similar cell dimensions, which
is not surprising since USP12 and USP46 have 88% sequence simi-
larity, although neither interface is fully conserved. A second crys-tal form for USP46/UAF1FL was determined in a different crystal
lattice (C2), with different packing, but even in this crystal lattice,
the USP still has maintained both interfaces (PDB code: 5CVO). The
striking similarity and conservation of these two USP/UAF1 inter-
faces among three different crystal structures suggested that this
was not due to a crystal packing artefact and further analysis of
the second interface would be worthwhile (Supp. Fig. 1a).
A superposition of our USP46 structure on USP12 in complex
with UAF1580 revealed no significant conformational change in
the USP moiety (RMSd on 309 Ca: 0.9 Å). When the UAF1 moieties
are compared by superposition of the UAF1580 onto the USP12FL-
Ub/UAF1580 complex, no conformational change is observed in
UAF1580 close to Interface 1 (Supp. Fig. 1b), whereas a large shift
is observed in the extended loop of blade 3, the region where
UAF1580 forms Interface 2 (Supp. Fig. 1c). This conformational
change due to interaction of UAF1580 at Interface 2 is also observed
in the USP46/UAF1 structure upon UAF1 binding (Yin et al., 2015).
Since the conformational change as well as the presence of two
UAF1 interfaces seems to be conserved between USP46 and
USP12, we wondered what stoichiometry the USP12/UAF1 com-
plex has in solution.3.2. The USP12/UAF1 complex has 1:2 stoichiometry
To study relative amounts of USP12 and UAF1 in solution we
carried out size exclusion chromatography coupled with multi-
angle laser scattering (SEC-MALLS) of the purified USP12FL-Ub/
UAF1580 complex which was used for obtaining the crystal struc-
ture. The molecular weight obtained from the MALLS experiment
was approximately 166 KDa which is much closer to the calculated
mass for 1:2 complex (180 KDa) than for a 1:1 complex (115 KDa).
The calculated molecular weight was not constant within the peak,
which suggests a dynamic equilibrium between the 1:2 and 1:1
complexes (Fig. 2a).
Next, we carried out small angle X-ray scattering (SAXS) exper-
iments coupled to size exclusion chromatography. At the high con-
centration necessary for SAXS experiments higher order species are
observed (Fig. 2b). The purified complex of USP12FL with covalently
bound Ub-PRG and UAF1FL was used for these experiments. Frames
corresponding to the different parts of the peak were averaged and
analysed separately (Supp. Fig. 1e). Molecular weight estimation of
the data (898–909) from the latter half of the peak was consistent,
when carried out using different methods (Porod volume (Konarev
et al., 2006), excluded volume from DAMMIF model (Franke and
Svergun, 2009), and SAXS MoW2 (Fischer et al., 2010)), where we
observed that USP12FL-Ub/UAF1FL has a molecular weight of 190
KDa corresponding to a 1:2 stoichiometry of the complex. Addi-
tionally, Porod analysis of the frames in the early half of the peak
corresponded to a molecular weight of 390 KDa indicating forma-
tion of high molecular weight species which fits well with the
MALLS data (Fig. 2b).
Moreover, we compared the experimental SAXS profile of
frames (898–909) with calculated scattering curves based on the
crystal structure either with one UAF1FL bound (in either of the
two sites), or with two UAF1FL molecules bound. We obtained a
much worse fit with the 1:1 profiles (Fig. 2c, e) compared to the
possible 1:2 profile (Fig. 2d). To further analyse these data, we
tested whether the OLIGOMER algorithm would change the fit.
Other possible options did not improve the fit, but when testing
for the 1:2 profile, we found an improved fit (Fig. 2f) with volume
fractions of 81% for the 1:2 complex and a smaller fraction for
UAF1FL (19%). In principle such a fraction was expected to be a mix-
ture of the 1:1 complex and UAF1FL. It is possible that the compu-
tational analysis selects against this complex mixture when
fractions are small.
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Fig. 2. USP12/UAF1 has 1:2 stoichiometry. A) SEC-MALLS analysis of USP12FL-Ub/UAF1580 (8 lM) shows a molecular weight corresponding to a 1:2 complex. B) SEC-MALLS
analysis of USP12FL-Ub/UAF1FL at high concentration (42 lM) shows a dynamic equilibrium between high molecular weight species and the 1:2 complex in agreement with
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We investigated if the two binding events indicative of the 1:2
stoichiometry could be observed in an in vitro binding experiment.
Therefore, we analysed the binding of UAF1FL to GST-USP12WT by
Surface Plasmon Resonance (SPR) and indeed observed two dis-
tinct binding events (Fig. 3a). We found a high-affinity binding
(Kd = 4 nM) with an extremely low off-rate, which saturated at100 nM. Moreover, when we added higher concentrations of
UAF1FL, a second binding event could be observed (Kd = 325 nM)
(Fig. 3b) with faster binding and dissociation. In conclusion, we
observed two binding events for UAF1FL binding to USP12WT with
different binding characteristics.
We tested which of these events contributed to activation. We
performed an enzymatic assay against the minimal substrate
ubiquitin rhodamine (Ub-Rho), as a function of activator
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Table 2
Michaelis Menten analysis of USP12WT with UAF1.
Protein Kcat (102s1) KM (lM) Kcat/KM (M1 s1)
USP12WT (100 nM) 0.076 50 0.15  102
USP12WT + UAF1 (100 nM) 2.6 50 5.20  102
USP12WT + UAF1 (1250 nM) 3.3 64 5.15  102
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with the high-affinity binding site. In contrast, the second binding
event does not affect the activation status, as no further activa-
tion is observed when the UAF1FL binds the second site
(Fig. 3c, d). We then performed a kinetic analysis of USP12 activ-
ity, either at equal concentration to UAF1 (1:1) or when an excessUAF1FL Concentration (nM)
R
es
po
ns
e
(R
U
)
0. 1 1 10 100 1000 10000
-2 0
0
20
40
60
80
100
KdHigh - 4.3 ± 0.5 nM
KdLow - 325 ± 109 nM
B
D
10 100 1000
0. 0
0. 1
0. 2
0. 3
UAF1FL Concentration  (nM)
R
at
e 
(n
M
/s
)
USP12 WT
sis of five successive injections of UAF1FL on immobilized USP12WT, raw data show
st off-rates. B) Fitting quantitative SPR analysis of UAF1FL to USP12WT, obtained from
indicated. C) Cleavage of Ub-Rhodamine by USP12WT at different concentrations of
ncentration shows the importance of high affinity site for activation. E) Michaelis
1FL (100 nM, 1250 nM) shows that the second binding of UAF1 leads to no further
444 S. Dharadhar et al. / Journal of Structural Biology 196 (2016) 437–447of UAF1 is present (Fig. 3e). The Michaelis Menten parameters
Kcat and KM did not change with higher UAF1 concentration, con-
firming that only Interface 1 is important for UAF1 mediated
USP12 activation (Table 2).
3.4. The Fingers sub-domain in USP12 is crucial for binding and
activation by UAF1
We validated the role of Interface 1 by making a series of muta-
tions. In line with their role in the USP46/UAF1 interface (Yin et al.,
2015), a triple mutant (UAF13X = K214E + W256A + R272D) on
UAF1 and a reciprocal mutant (E190K) on USP12 interfered with
high affinity binding (Fig. 4a, b). The high affinity binding could
be partially rescued by combining the USP12E190K with the UAF13X
mutant, in a similar fashion to what was observed for USP46 and
UAF1 binding (Fig. 4c) (Yin et al., 2015). Additionally, the binding0 200 400 600 800
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On comparing the binding characteristics of these mutants with
USP12WT, we noted that the UAF13X mutant only binds at very high
concentrations and does not release easily, while the USP12E190K
mutant binds with a fast release (Fig. 4a). We also made a series
of mutations at Interface 2 on USP12WT, by either reversing charges
(R217E or R285D) or changing the hydrophobic interface (F287A)
but none of them could disrupt binding of UAF1 to this site
(Fig. 4g, h).
We then carried out an in vitro Ub-Rho assay to analyse the
effects of these mutations on USP12 activation and compare it with
previously published findings for USP46 (Yin et al., 2015). Wild
type UAF1 was unable to activate USP12E190K to similar levels as
compared to USP12WT (Fig. 4d, e) and similarly, the UAF13X mutant
did no longer activate. However, as shown previously for USP46/
UAF1 (Yin et al., 2015), the combination of these complementarytration (nM)
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tance of the fingers sub domain in USP12 and USP46 (Yin et al.,
2015) activation by UAF1.3.5. The two-step binding is conserved in USP1
Some aspects of USP1 regulation are different from the USP12
and USP46, as USP1 is a much larger enzyme, and it cannot be
hyper-activated by WDR20. We therefore wondered whether the
1:2 stoichiometry is also conserved in this important DNA repair
enzyme. We carried out SEC-MALLS of the purified USP1/UAF1
complex and the molecular weight obtained was approximately
220 KDa which closely corresponds to the 1:2 complex (235
KDa) rather than a 1:1 complex (160 KDa). Similar to the USP12/
UAF1 MALLS data (Fig. 2a), the molecular weight was not constant
within the peak suggesting a dynamic equilibrium between the
two states of the complex (Fig. 5a). We then performed the UAF1
binding assay with His-USP1 on the SPR chip (Fig. 5b, c). Again,
we observed a two-step binding, and although the high RU values
for the second step suggests an additional unexplained background
process, the fitting identified similar affinities for USP1 to those
observed for USP12. Thus from our SPR result in addition to the
MALLS data, we could confirm the presence of this unusual two-
step binding in USP1.1nM
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fingers sub-domain which activates USP12 and then UAF1 also binds on the backside of4. Discussion and conclusions
Here we present a series of structures that contribute to the
understanding of regulation of DUBs by non-substrate partners.
In our analysis we identified two possible binding sites for
UAF1 on USP12-Ub (Fig. 5d), that are conserved from USP46.
The two UAF1 binding sites are distant from the catalytic centre
and binding of UAF1 did not induce significant rearrangements
in the USP structure. Thus it is very hard to envision from these
structures how USP12 is activated by UAF1, especially when the
activation is due to an increase in kcat and not KM. It is possible
that UAF1 binding stabilizes the flexible USP12 ‘‘fingers”, trans-
forming it into a catalytically proficient state and this may not
be visible since we compare it to a ubiquitin-bound USP struc-
ture. Therefore an apo-structure of USP12 could shed more light
on this issue.
The binding analysis shows that Interface 1 provides the high
affinity interaction that is responsible for the activation of the
USP. We measure a binding affinity in the order of 4 nM with
extremely slow dissociation. The affinity is less tight than the
0.1 nM observed for USP46 by Yin et al., 2015, most likely due
to differences in the experimental setup. Their lowest concentra-
tion of UAF1 used was far above the reported KD (sevenfold), and
the KD was estimated based on very slow dissociation constant
derived from the global kinetic fit. Overall, the structure ofUAF1FL Concentration (nM)
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Interface 1 bears close resemblance to the published data on
USP46 (Yin et al., 2015), again highlighting the high degree of
conservation between these USPs. The Interface 1 has a relatively
small surface area, with a predominance of charged interactions.
For such a small interface, even the observed affinity of 4 nM is
rather surprising since such strong binding between two pro-
teins is rarely mediated by interfaces having less than 1000 Å2
buried surface area (Chen et al., 2013). However, previous
reports have suggested the importance of the fingers domain
for UAF1 binding and activation (Olazabal-Herrero et al., 2015).
It is still unclear how S313 phosphorylation which is present
in the long insert of USP1 could play a role in UAF1 binding
(Villamil et al., 2012b), as the (shorter) corresponding region
on USP12 is not involved in UAF1 binding for either of the
interfaces.
In the USP12/UAF1580 complex we observe a conserved second
interface (Interface 2) at the backside of the ubiquitin binding cleft.
The buried surface area of this interface is larger than for Interface
1, and the contact is more hydrophobic, indicating that its proper-
ties are very different. Our binding data confirm the presence of a
secondary interaction, with an affinity of 300 nM and fast kinet-
ics. Unfortunately we were unable to validate this interface by
mutational analysis. It is possible that this is due to the large sur-
face area involved in this binding. Additionally the surface shape
complementarity between the extended loop in USP12 and the rel-
atively concave architecture of ancillary domain and b-propeller in
the UAF1 molecule could contribute to the interaction primarily by
backbone interactions.
The two binding interfaces on UAF1 seem independent of each
other as they reside in distant parts of the protein. Thus mutating
residues on Interface 1 is unlikely to affect binding to Interface 2 or
vice versa. Our binding studies with the UAF13X mutant showed
binding to the high affinity site at very high concentrations and
no binding to the low affinity site. This could mean that UAF1
can only bind the low affinity site once the high affinity site has
been fully occupied. It is possible that high overall flexibility in
USP12 in the unbound state prevents binding to the low affinity
site, thereby making the high affinity binding mandatory for bind-
ing the second UAF1.
During revision of this manuscript, a structure for the USP12/
UAF1/WDR20 complex was published (Li et al., 2016). In this struc-
ture WDR20 binds to a number of structural elements at the palm
domain of USP12 with an affinity of 7 nM. Interestingly, the bind-
ing interface for WDR20 partially overlaps with the second binding
site of UAF1 on USP12 (Supp. Fig. 1d), but the contacts are very dif-
ferent, explaining how a F287A/V279D mutation can disrupt
WDR20 binding whereas F287A does not affect the UAF1 interface,
which is dominated by backbone interactions in this area. The par-
tial overlap of the binding interfaces and the high affinity of
WDR20 suggests that WDR20 binding to USP12/UAF1 can either
prevent binding of the second UAF1 molecule or it can actively
compete out UAF1 if it is bound to the USP12/UAF1 complex. The
partial overlap of this interface could hint towards a possible reg-
ulatory role for the second UAF1 binding.
The second binding of UAF1 to USP12 does not seem to play
a role in the activation of USP12 on a minimal substrate. Mean-
while the effect of the second UAF1 binding on the catalytic
activity of USP12 against one of its natural substrates remains
to be tested and this could yield more insight on the possible
function of this regulatory event. In any case, the conservation
of the 1:2 stoichiometry and the two step binding of UAF1 in
this small family of USPs highlights the importance of the sec-
ond binding and implies that the binding could be important
for functions which are independent of activation on a minimal
substrate.All available data (Cohn et al., 2009; Sowa et al., 2009) and the
high affinity with slow off-rates indicate that USP12/UAF1 form a
constitutive complex in cells. In contrast, the fast kinetics of the
second binding site indicates that it could play a role in regulation.
This is in line with the recent quantitative analysis of protein abun-
dance in HeLa cells that place the concentration of USP12 and UAF1
at 2 and 77 nM, respectively (Hein et al., 2015). At that concentra-
tion the first interface would be fully saturated, and a significant
fraction of the USPs would start to bind a second molecule. This
means that the second binding could potentially play an important
regulatory role.
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